Another Blow To Aduhelm As Biogen Withdraws EU Filing

Adds To US Commercial Failure

 
• By Andrew McConaghie and Neena Brizmohun
  
Biogen
Biogen has withdrawn its filing with the EMA but has indicated it could resubmit if the evidence base changes. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip